Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €22.10 EUR
Change Today +0.16 / 0.73%
Volume 19.0K
QIA On Other Exchanges
Symbol
Exchange
Xetra
NASDAQ GS
As of 4:03 AM 06/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Detlev H. Riesner Ph.D.

Co-Founder, Qiagen NV
AgeTotal Calculated CompensationThis person is connected to 35 board members in 4 different organizations across 6 different industries.

See Board Relationships
72--

Background*

Dr. Detlev H. Riesner, Ph.D. has been Vice President of Research at the University of Düsseldorf since 1996. Dr. Riesner is an International Leader in Prion and Alzheimer's Research - Member. He was a Professor of Biophysical Chemistry at the Darmstadt Institute of Technology and from 1975 to 1977, Lecturer of Biophysical Chemistry at Hannover Medical School. He has held guest professorships at the Institute of Microbiology, Academia Sinica, Beijing and the Department ...

Read Full Background

Corporate Headquarters*

Spoorstraat 50
Venlo, Limburg 5911 KJ

Netherlands

Phone: 31 77 320 8400
Fax: 31 77 320 8409

Board Members Memberships*

Member of the Scientific Advisory Board and Director
2007-Present
Director

Education*

Master's Degree
Princeton University
Postgraduate Diploma
Princeton University
PhD
Technische Universität Carolo-Wilhelmina zu Braunschweig
MS
Gottfried Wilhelm Leibniz Universität Hannover

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
QIA:GR €22.10 EUR +0.16

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John L. Bishop Chairman, Chief Executive Officer and Member of Equity Incentive Committee
Cepheid
$664.9K
Peter D. Meldrum Ph.D.Chief Executive Officer, President and Director
Myriad Genetics Inc.
$997.0K
Marc D. Grodman M.D.Founder, Chairman, Chief Executive Officer, President and Managing Director
Bio-Reference Laboratories Inc.
$1.2M
Robert F. Friel Chairman, Chief Executive Officer, President and Member of Finance Committee
PerkinElmer Inc.
$1.0M
Alexandre Merieux Chief Executive Officer, Director and Member of Strategy Committee
bioMérieux SA
€669.5K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QIAGEN N.V., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.